Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NM-IL-12 in Open Surgical Wounds Following Colostomy Takedown
NCT02544061Phase 2Completed
- Sponsor
- Neumedicines Inc.
- Start
- Mar 2016
- Primary completion
- Oct 2017
- Modality
- Cytokines & Interferons
- Countries
- 1
01
Overview
A Phase 2 trial of HemaMax in surgical wound, sponsored by Neumedicines Inc.. Started Mar 2016; status: completed.
02
Drugs
HemaMax
03
Conditions
surgical wound
Beyond the preview
Go deeper on NCT02544061.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02544061.